Vermillion Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$363 Sell
27
-1
-4% -$12 ﹤0.01% 1495
2026
Q1
$166 Buy
28
+1
+4% +$8 ﹤0.01% 1362
2025
Q4
$191 Hold
27
﹤0.01% 591
2025
Q3
$284 Hold
27
﹤0.01% 1499
2025
Q2
$257 Sell
27
-3
-10% -$31 ﹤0.01% 509
2025
Q1
$439 Buy
30
+1
+3% +$15 ﹤0.01% 1260
2024
Q4
$433 Buy
+29
New +$473 ﹤0.01% 506

Other funds holding OGN

Vermillion Wealth Management's OGN Position: Q2 2026 in Review

Vermillion Wealth Management reduced its Organon & Co (OGN) stake by 3.6% in Q2 2026, selling an estimated $12 and leaving 27 shares worth $363. The position accounts for ﹤0.01% of the portfolio, ranked #1495.

Vermillion Wealth Management first reported a position in OGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $439 in Q1 2025. 107 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Vermillion Wealth Management held 27 shares of Organon & Co worth $363 as of Q2 2026.
  • Vermillion Wealth Management sold 1 Organon & Co share in Q2 2026, an estimated $12.
  • Organon & Co made up ﹤0.01% of Vermillion Wealth Management's portfolio in Q2 2026, its #1495 holding.
  • Vermillion Wealth Management first reported a position in Organon & Co in Q4 2024 and has held it in 7 quarters since.
  • Vermillion Wealth Management's Organon & Co position peaked at $439 in Q1 2025.
  • 107 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.